These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21325980)

  • 1. The C-terminus of Hsp70-interacting protein promotes Met receptor degradation.
    Jang KW; Lee JE; Kim SY; Kang MW; Na MH; Lee CS; Song KS; Lim SP
    J Thorac Oncol; 2011 Apr; 6(4):679-87. PubMed ID: 21325980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.
    Shattuck DL; Miller JK; Laederich M; Funes M; Petersen H; Carraway KL; Sweeney C
    Mol Cell Biol; 2007 Mar; 27(5):1934-46. PubMed ID: 17178829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin ligase CHIP selectively regulates mutant epidermal growth factor receptor by ubiquitination and degradation.
    Chung C; Yoo G; Kim T; Lee D; Lee CS; Cha HR; Park YH; Moon JY; Jung SS; Kim JO; Lee JC; Kim SY; Park HS; Park M; Park DI; Lim DS; Jang KW; Lee JE
    Biochem Biophys Res Commun; 2016 Oct; 479(2):152-158. PubMed ID: 27475501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
    To C; Seiden I; Liu N; Wigle D; Tsao MS
    Exp Cell Res; 2002 Feb; 273(1):45-53. PubMed ID: 11795945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations lead to an oncogenic deletion of met in lung cancer.
    Kong-Beltran M; Seshagiri S; Zha J; Zhu W; Bhawe K; Mendoza N; Holcomb T; Pujara K; Stinson J; Fu L; Severin C; Rangell L; Schwall R; Amler L; Wickramasinghe D; Yauch R
    Cancer Res; 2006 Jan; 66(1):283-9. PubMed ID: 16397241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.
    Nishimura Y; Takiguchi S; Ito S; Itoh K
    Int J Oncol; 2014 Feb; 44(2):412-26. PubMed ID: 24297483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.
    Kim DG; Lee JY; Lee JH; Cho HY; Kang BS; Jang SY; Kim MH; Guo M; Han JM; Kim SJ; Kim S
    Cancer Res; 2016 Jun; 76(11):3422-36. PubMed ID: 27197155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.
    Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J
    Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Antitumor Effect of C-terminus of Hsp70-Interacting Protein via Degradation of c-Met in Small Cell Lung Cancer.
    Cho SH; Kim JI; Kim HS; Park SD; Jang KW
    Korean J Thorac Cardiovasc Surg; 2017 Jun; 50(3):153-162. PubMed ID: 28593150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
    Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
    Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.
    Kao SH; Wang WL; Chen CY; Chang YL; Wu YY; Wang YT; Wang SP; Nesvizhskii AI; Chen YJ; Hong TM; Yang PC
    Oncogene; 2014 Jun; 33(24):3172-82. PubMed ID: 23851495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
    Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
    Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
    Fan M; Park A; Nephew KP
    Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells.
    Matsubara D; Ishikawa S; Oguni S; Aburatani H; Fukayama M; Niki T
    J Thorac Oncol; 2010 Sep; 5(9):1317-24. PubMed ID: 20736805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MET increases the sensitivity of gefitinib-resistant cells to SN-38, an active metabolite of irinotecan, by up-regulating the topoisomerase I activity.
    Sakai A; Kasahara K; Ohmori T; Kimura H; Sone T; Fujimura M; Nakao S
    J Thorac Oncol; 2012 Sep; 7(9):1337-44. PubMed ID: 22722827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cao L; Wang F; Li S; Wang X; Huang D; Jiang R
    Cancer Lett; 2019 Mar; 444():116-126. PubMed ID: 30583073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
    Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
    Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.